UK Weighing Rx-to-OTC Switch Of Menopause Treatment
Executive Summary
Novo Nordisk is seeking to switch from Rx-to-OTC status Gina (estradiol hemihydrate), which, if approved, would be the first form of local hormone replacement therapy available without a prescription in the UK.
You may also be interested in...
Rx-to-OTC Switch Of Menopause Treatment Approved In UK
Women in the UK will soon have OTC access to a low-dose Hormone Replacement Therapy drug following the reclassification of Novo Nordisk's Gina.
UK Looks To Switch Overactive Bladder Treatment
Maxwellia is seeking its second first-in-class switch in the UK with an application to reclassify from prescription-only to pharmacy status overactive bladder treatment Aquiette.
HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives
The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month.